The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies

Clinical Nutrition

Volumn 33, Issue 4, 2014, Pages 571-580

  Li, Li ^a   Somerset, Shawn ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

Chronic inflammation; Cystic fibrosis; Diet therapy; Gut microbiota

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; BIODIVERSITY; CLOSTRIDIUM; CYSTIC FIBROSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET THERAPY; ENERGY EXPENDITURE; ENTEROBACTERIACEAE; FIRMICUTES; FUSOBACTERIUM; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RELEASE; INTESTINE FLORA; INTESTINE MUCOSA; MALNUTRITION; NONHUMAN; NUTRITIONAL STATUS; REVIEW; SPECIES DIVERSITY; SPECIES RICHNESS; STREPTOCOCCUS BOVIS; CHRONIC DISEASE; COMPLICATION; DIET; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA;

CHRONIC DISEASE; CYSTIC FIBROSIS; DIET; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; MICROBIOTA; NUTRITIONAL STATUS; PREBIOTICS; PROBIOTICS;

EID: 84902366435     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.04.004     Document Type: Review

References (117)

1. Garcia M.A.S., Quinton P.M., Yang N. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. JClin Invest 2009, 119:2613-2622.
2. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
3. Parkins M.D., Parkins V.M., Rendall J.C., Elborn S. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Ther Adv Respir Dis 2011, 5:105-119.
4. Hirche T., Stein J., Hirche H., Hausmann J., Wagner T., Behrens F., et al. Increased levels of anti-glycan antibodies in patients with cystic fibrosis. Eur J Med Res 2011, 16:385-390.
5. Werlin S.L., Benuri-Silbiger I., Kerem E., Adler S.N., Goldin E., Zimmerman J., et al. Evidence of intestinal inflammation in patients with cystic fibrosis. JPediatr Gastroenterol Nutr 2010, 51:304-308.
6. Sjögren K., Engdahl C., Henning P., Lerner U.H., Tremaroli V., Lagerquist M.K., et al. The gut microbiota regulates bone mass in mice. JBone Miner Res 2012, 27:1357-1367.
7. Larsen N., Vogensen F.K., van den Berg F.W.J., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010, 5:e9085. 10.1371/journal.pone.0009085.
8. Liu J., Wu D., Ahmed A., Li X., Ma Y., Tang L., et al. Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals. Curr Microbiol 2012, 65:7-13.
9. Prakash S., Rodes L., Coussa-Charley M., Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biol Target Ther 2011, 5:71-86.
10. Wells J.M., Rossi O., Meijerink M., van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 2011, 108:4607-4614.
11. Quon B.S., Aitken M.L. Cystic fibrosis: what to expect now in the early adult years. Paediatr Respir Rev 2012, 13:206-214.
12. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010, 10:735-744.
13. Ley R.E. Obesity and the human microbiome. Curr Opin Gastroenterol 2010, 26:5-11.
14. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
15. O'Keefe S.J. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 2008, 24:51-58.
16. Tilg H., Kaser A. Gut microbiome, obesity, and metabolic dysfunction. JClin Invest 2011, 121:2126-2132.
17. Macfarlane S., Steed H., Macfarlane G.T. Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci 2009, 46:25-54.
18. Corey M., McLaughlin F.J., Williams M., Levison H. Acomparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. JClin Epidemiol 1988, 41:583-591.
19. Dray X., Kanaan R., Bienvenu T., Desmazes-Dufeu N., Dusser D., Marteau P., et al. Malnutrition in adults with cystic fibrosis. Eur J Clin Nutr 2004, 59:152-154.
20. Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Micro 2011, 9:279-290.
21. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.-Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
22. Muegge B.D., Kuczynski J., Knights D., Clemente J.C., González A., Fontana L., et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011, 332:970-974.
23. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
24. Duytschaever G., Huys G., Bekaert M., Boulanger L., De Boeck K., Vandamme P. Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol 2011, 77:8015-8024.
25. Duytschaever G., Huys G., Bekaert M., Boulanger L., De Boeck K., Vandamme P. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. JCyst Fibros 2012, 12:206-215.
26. Madan J.C., Koestler D.C., Stanton B.A., Davidson L., Moulton L.A., Housman M.L., et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio 2012, 3:e00251-12. 10.1128/mBio.00251-12.
27. Sánchez-Calvo J., García-Castillo M., Lamas A., Rodriguez-Baños M., Máiz L., Suárez L., et al. Gut microbiota composition in cystic fibrosis patients: molecular approach and classical culture. JCyst Fibros 2008, 7(Suppl.2):S50.
28. Scanlan P.D., Buckling A., Kong W., Wild Y., Lynch S.V., Harrison F. Gut dysbiosis in cystic fibrosis. JCystic Fibros 2012, 11:454-455.
29. Jernberg C., Löfmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156:3216-3223.
30. Rafii F., Sutherland J.B., Cerniglia C.E. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manag 2008, 4:1343-1357.
31. Castellarin M., Warren R.L., Freeman J.D., Dreolini L., Krzywinski M., Strauss J., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012, 22:299-306.
32. Chen Y., Yang F., Lu H., Wang B., Chen Y., Lei D., et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011, 54:562-572.
33. Roberts G.L. Fusobacterial infections: an underestimated threat. Br J Biomed Sci 2000, 57:156-162.
34. Woodmansey E.J. Intestinal bacteria and ageing. JAppl Microbiol 2007, 102:1178-1186.
35. Kaplan C.W., Lux R., Haake S.K., Shi W. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol 2009, 71:35-47.
36. Probert H., Gibson G. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 2002, 3:23-27.
37. Macfarlane S., Dillon J.F. Microbial biofilms in the human gastrointestinal tract. JAppl Microbiol 2007, 102:1187-1196.
38. Westermarck E., Myllys V., Aho M. Effect of treatment on the jejunal and colonic bacterial flora of dogs with exocrine pancreatic insufficiency. Pancreas 1993, 8:559-562.
39. Hamer H.M., De Preter V., Windey K., Verbeke K. Functional analysis of colonic bacterial metabolism: relevant to health?. Am J Physiol Gastrointest Liver Physiol 2011, 302:G1-G9.
40. Domínguez-Muñoz J.E. Pancreatic exocrine insufficiency: diagnosis and treatment. JGastroenterol Hepatol 2011, 26:12-16.
41. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177:995-1001.
42. Delhaes L., Monchy S., Fréalle E., Hubans C., Salleron J., Leroy S., et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS ONE 2012, 7:e36313. 10.1371/journal.pone.0036313.
43. Filkins L.M., Hampton T.H., Gifford A.H., Gross M.J., Hogan D.A., Sogin M.L., et al. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. JBacteriol 2012, 194:4709-4717.
44. Guss A.M., Roeselers G., Newton I.L.G., Young C.R., Klepac-Ceraj V., Lory S., et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 2011, 5:20-29.
45. Rogers G.B., Carroll M.P., Hoffman L.R., Walker A.W., Fine D.A., Bruce K.D. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes 2010, 1:85-93.
46. Hansen C.H.F., Nielsen D.S., Kverka M., Zakostelska Z., Klimesova K., Hudcovic T., et al. Patterns of early gut colonization shape future immune responses of the host. PLoS ONE 2012, 7:e34043. 10.1371/journal.pone.0034043.
47. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177. 10.1371/journal.pbio.0050177.
48. Thompson C.L., Wang B., Holmes A.J. The immediate environment during postnatal development has long-term impact on gut community structure in pigs. ISME J 2008, 2:739-748.
49. Bruzzese E., Raia V., Spagnuolo M.I., Volpicelli M., De Marco G., Maiuri L., et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007, 26:322-328.
50. Weiss B., Bujanover Y., Yahav Y., Vilozni D., Fireman E., Efrati O. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010, 45:536-540.
51. Gillanders L., Elborn J.S., Gilpin D., Schneiders T., Tunney M. The airway microbiome in cystic fibrosis: challenges for therapy. Therapy 2011, 8:645-660.
52. Bruzzese E., Raia V., Gaudiello G., Polito G., Buccigrossi V., Formicola V., et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004, 20:813-819.
53. Norkina O., Kaur S., Ziemer D., De Lisle R.C. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1032-G1041.
54. Raia V., Maiuri L., de Ritis G., de Vizia B., Vacca L., Conte R., et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 2000, 47:344-350.
55. Lloyd-Still J.D. Crohn's disease and cystic fibrosis. Dig Dis Sci 1994, 39:880-885.
56. Cucchiara S., Iebba V., Conte M.P., Schippa S. The microbiota in inflammatory bowel disease in different age groups. Dig Dis 2009, 27:252-258.
57. De Cruz P., Prideaux L., Wagner J., Ng S.C., McSweeney C., Kirkwood C., et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 2012, 18:372-390.
58. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009, 15:1183-1189.
59. Willing B.P., Dicksved J., Halfvarson J., Andersson A.F., Lucio M., Zheng Z., et al. Apyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139:1844-1854.e1.
60. Guarner F., Malagelada J.-R. Gut flora in health and disease. Lancet 2003, 361:512-519.
61. Ojetti V., Gigante G., Ainora M.E., Fiore F., Barbaro F., Gasbarrini A. Microflora imbalance and gastrointestinal diseases. Dig Liver Dis Suppl 2009, 3:35-39.
62. Rubin D.C., Shaker A., Levin M.S. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012, 3:1-10.
63. Davis C.D., Milner J.A. Gastrointestinal microflora, food components and colon cancer prevention. JNutr Biochem 2009, 20:743-752.
64. Fischer R., Simmerlein R., Huber R.M., Schiffl H., Lang S.M. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 2007, 42:1193-1197.
65. Ngan D., Wilcox P., Aldaabil M., Li Y., Leipsic J., Sin D., et al. The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis. BMC Pulm Med 2012, 12:3.
66. Hillman M., Eriksson L., Mared L., Helgesson K., Landin-Olsson M. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus. JCyst Fibros 2012, 11:144-219.
67. Manco M., Putignani L., Bottazzo G.F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010, 31:817-844.
68. Burcelin R., Serino M., Chabo C., Blasco-Baque V., Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 2011, 48:257-273.
69. Vrieze A., Holleman F., Zoetendal E., de Vos W., Hoekstra J., Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010, 53:606-613.
70. Farrell G.C., van Rooyen D., Gan L., Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012, 6:149-171.
71. Fiorotto R., Scirpo R., Trauner M., Fabris L., Hoque R., Spirli C., et al. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology 2011, 141:1498-1508.e5.
72. Lacativa P.G.S., Farias MLFd Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 2010, 54:123-132.
73. Figueroa V., Milla C., Parks E.J., Schwarzenberg S.J., Moran A. Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr 2002, 75:1005-1011.
74. Georgiopoulou V.V., Denker A., Bishop K.L., Brown J.M., Hirsh B., Wolfenden L., et al. Metabolic abnormalities in adults with cystic fibrosis. Respirology 2010, 15:823-829.
75. Rhodes B., Nash E.F., Tullis E., Pencharz P.B., Brotherwood M., Dupuis A., et al. Prevalence of dyslipidemia in adults with cystic fibrosis. JCyst Fibros 2010, 9:24-28.
76. Hull J.H., Garrod R., Ho T.B., Knight R.K., Cockcroft J.R., Shale D.J., et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J 2009, 34:1322-1328.
77. Onady G., Farinet C. An adult cystic fibrosis patient presenting with persistent dyspnea: case report. BMC Pulm Med 2006, 6(9).
78. Gordon C.M., Anderson E.J., Herlyn K., Hubbard J.L., Pizzo A., Gelbard R., et al. Nutrient status of adults with cystic fibrosis. JAm Diet Assoc 2007, 107:2114-2119.
79. Smith C., Winn A., Seddon P., Ranganathan S. Afat lot of good: balance and trends in fat intake in children with cystic fibrosis. JCyst Fibros 2012, 11:154-157.
80. Tlaskalova-Hogenova H., Stepankova R., Kozakova H., Hudcovic T., Vannucci L., Tuckova L., et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011, 8:110-120.
81. Dougherty K.A., Schall J.I., Stallings V.A. Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis. Am J Clin Nutr 2010, 92:660-667.
82. Rashid M., Durie P., Andrew M., Kalnins D., Shin J., Corey M., et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999, 70:378-382.
83. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
84. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
85. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. Ahuman gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
86. Hill M. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 1997, 6:S43-S45.
87. Maqbool A., Stallings V.A. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 2008, 14:574-581.
88. Nicolaidou P., Stavrinadis I., Loukou I., Papadopoulou A., Georgouli H., Douros K., et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 2006, 165:540-545.
89. McCabe H. Riboflavin deficiency in cystic fibrosis: three case reports. JHum Nutr Diet 2001, 14:365-370.
90. Nalepa B., Siemianowska E., Skibniewska K.A. Influence of Bifidobacterium bifidum on release of minerals from bread with differing bran content. JToxicol Environ Health A 2011, 75:1-5.
91. Pond M.N., Morton A.M., Conway S.P. Functional iron deficiency in adults with cystic fibrosis. Respir Med 1996, 90:409-413.
92. von Drygalski A., Biller J. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract 2008, 23:557-563.
93. Lyczak J.B. Commensal bacteria increase invasion of intestinal epithelium by Salmonella enterica serovar Typhi. Infect Immun 2003, 71:6610-6614.
94. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013, 110:9066-9071.
95. Bron P.A., van Baarlen P., Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Micro 2012, 10:66-78.
96. Tsay T.B., Yang M.C., Chen P.H., Hsu C.M., Chen L.W. Gut flora enhance bacterial clearance in lung through toll-like receptors 4. JBiomed Sci 2011, 18:68.
97. Sadikot R.T., Zeng H., Joo M., Everhart M.B., Sherrill T.P., Li B., et al. Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. JImmunol 2006, 176:4923-4930.
98. Folkesson A., Jelsbak L., Yang L., Johansen H.K., Ciofu O., Hoiby N., et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Micro 2012, 10:841-851.
99. Romond M.-B., Mullié C., Colavizza M., Revillion F., Peyrat J.-P., Izard D. Intestinal colonization with bifidobacteria affects the expression of galectins in extraintestinal organs. FEMS Immunol Med Microbiol 2009, 55:85-92.
100. Infante P.D., Redecillas F.S., Torrent V.A., Segarra C.O., Maldonado S.M., Gartner T.L., et al. Improvement of intestinal function in cystic fibrosis patients using probiotics. Ann Pediatr (Barc) 2008, 69:501-505.
101. Jalanka-Tuovinen J., Salonen A., Nikkilä J., Immonen O., Kekkonen R., Lahti L., et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 2011, 6:e23035. 10.1371/journal.pone.0023035.
102. Kumar M., Kumar A., Nagpal R., Mohania D., Behare P., Verma V., et al. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr 2010, 61:473-496.
103. Kok N.N., Morgan L.M., Williams C.M., Roberfroid M.B., Thissen J.-P., Delzenne N.M. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. JNutr 1998, 128:1099-1103.
104. Kolida S., Gibson G.R. Synbiotics in health and disease. Annu Rev Food Sci Technol 2011, 2:373-393.
105. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. JAm Diet Assoc 2008, 108:832-839.
106. de Wit N.J., Derrien M., Bosch-Vermeulen H., Oosterink E., Keshtkar S., Duval C., et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol 2012, 303:G589-G599.
107. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat Immunol 2011, 12:5-9.
108. Vaisman N., Tabachnik E., Sklan D. Short-chain fatty acid absorption in patients with cystic fibrosis. JPediatr Gastroenterol Nutr 1992, 15:146-149.
109. Looijer-Van Langen M.A.C., Dieleman L.A. Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 2009, 15:454-462.
110. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002, 22:283-307.
111. Abell G.C.J., Conlon M.A., McOrist A.L. Methanogenic archaea in adult human faecal samples are inversely related to butyrate concentration. Microb Ecol Health Dis 2006, 18:154-160.
112. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2009, 18:190-195.
113. Louis P., Scott K.P., Duncan S.H., Flint H.J. Understanding the effects of diet on bacterial metabolism in the large intestine. JAppl Microbiol 2007, 102:1197-1208.
114. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724.e2.
115. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006, 157:876-884.
116. Tzounis X., Rodriguez-Mateos A., Vulevic J., Gibson G.R., Kwik-Uribe C., Spencer J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 2011, 93:62-72.
117. Shen Q., Chen Y.A., Tuohy K.M. Acomparative invitro investigation into the effects of cooked meats on the human faecal microbiota. Anaerobe 2010, 16:572-577.